|
Departmental Adjunct Faculty
Raymond Tait, PhD
Raymond Tait is an Adjunct Professor of Health Care Ethics and Professor and Director of Research with the Department of Psychiatry at Saint Louis University's School of Medicine. He is also the chair of the Chair of the Biomedical Institutional Review Board atSaint Louis University. Raymond Tait completed his MA and PhD in Clinical-Social Psychology at University of Illinois at Chicago, and a post-doctoral fellowship and the University of Virginia Medical Center. Currently, he is the associate editor for the Pain Digest, Pain Medicine, and the Journal of Behavioral Medicine, as well as a reviewer for the Clinical Journal of Pain, Pain, Annals of Behavioral Medicine, Annals of Emergency Medicine, Journal of Consulting and Clinical Psychology, Professional Psychology: Theory and Practice, Journal of Behavioral Medicine, Social Science and Medicine, Journal of Pain, and the European Journal of Pain.
Selected Grants
Investigator-Initiated Grants
"Racial disparity in treating occupational low back injuries," Agency for Healthcare Research and Quality, R01, 9/05 – 8/09, $917,230. Investigator with Chibnall, J.T., Kalauokalani, D., & Luebbert, R.
"An open-label, flexible dose clinical trial of the short-term safety and efficacy of escitalopram in the treatment of naïve and treatment-refractory geriatric patients," Forest Laboratories, 1/04 – 1/05, $99,635. Co-principle investigator with LeFevre, P., et al.
"The Cancer Pain Inventory: instrument development and validation," Barnes-Jewish Foundation, 3/04 – 3/05, $70,000. Co-investigator with Deshields, T.L., et al.
"Race and outcomes in work-related back injuries. Agency for Healthcare Research and Quality," R01, 2/02 – 2/05, $827,129. Co-principle investigator with Chibnall, J.T.
"Oxcarbazapine (Trileptal ®) in the treatment of agitation in dementia – an open label, pilot, nursing home study," Novartis Pharmaceuticals, 10/01 – 10/03, $185,000. Co-investigator with others. Principle investigator: Grossberg, G.T.
"A prospective, single-blinded, repeated measures study of the effect of Rivastigmine on multiple cognitive domains in psychiatrically stabilized schizophrenic patients," Novartis Pharmaceuticals, 2/01 – 2/03, $100,310. Co-investigator with others. Principle investigator: Conway, C.
"Assessing pain in geriatric patients with advanced Alzheimer’s Disease. National Alzheimer’s Association," 10/01 - 10/04, $230,000. Co-principal investigator with Chibnall, J.T.
Sponsor-Initiated Grants
"Conversion from Depakote- DR to Depakote-ER in the elderly." Sub-investigator with others. Principal investigator: Grossberg, G.T.
"A double-blind, flexible- dose comparison of the safety and efficacy of Escitalopram and placebo in the treatment of geriatric depression," Forest Laboratories, March 2003. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"Duloxetine versus placebo in the treatment of elderly patients with major depressive disorder," Lilly, March 2003. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of Neramexane in patients with moderate to severe dementia of the Alzheimer’s type: NER-MD-02," Forest Laboratories, February 2003. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of Neramexane in patients with moderate to severe dementia of the Alzheimer’s type: NER–MD–01," Forest Laboratories, February 2003. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"A phase II double-blind, randomized, dose-ranging, placebo-controlled, multicenter, safety and efficacy evaluation of three doses of NS 2330 in patients with mild to moderate dementia of the Alzheimer’s type," Boehringer-Ingelheim, April 2003. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"A prospective, 26-week, single-arm, open-label, multicenter, pilot study evaluating the efficacy and safety of Exelon 3 to 12 mg/day in patients with mixed dementia," Novartis, August 2002. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"A prospective, randomized start, multicenter, double-blinded, concurrently placebo-controlled study to evaluate the effect of flow-regulated ventriculoperitoneal shunting on progression of Alzheimer’s disease: an investigation of the safety and effectiveness of the Cognishunt CNS fluid shunt system," Eunoe, March 2002. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"An open label, 52-week, extension to a 24-week prospective, randomized, multicenter, double-blind, placebo- controlled, parallel-group comparison of the efficacy, tolerability, and safety of 3 – 12 mg.day of Exelon (Rivastigmine) capsules in patients with probable vascular dementia," Novartis, November 2002. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of Memantine in patients with mild to moderate dementia of the Alzheimer’s type," Forest Laboratories, August 2002, $121,000. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"A multi-center, double-blind, randomized comparison of the efficacy and safety of Quetiapine Fumarate (Seroquel) and Risperidone (Risperdal) in the treatment of patients with schizophrenia," AstraZeneca, 2001, $88,000. Principal investigator with others.
"A randomized, double-blind, placebo-controlled, flexible dosage trial to evaluate the efficacy and tolerability of paroxetine CR in patients with Generalized Anxiety Disorder (GAD)," GlaxoSmithKline, 2001, $87,828. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"A 52-week prospective, randomized, multi-center, double-blind, placebo-controlled, parallel-group comparison of the efficacy, tolerability, and safety of 3 – 12 mg/day of Exelon (Rivastigmine) capsules in patients with probable vascular dementia," Novartis, 2001, $125,879. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of Memantine in patients with moderate to severe dementia of Alzheimer’s type: MEM-MD-03," Forest Laboratories, 2002. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of Memantine in patients with moderate to severe dementia of the Alzheimer’s type: MEM-MD-02," Forest Laboratories, 2001, $121,000. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of Memantine in patients with moderate to severe dementia of the Alzheimer’s type: MEM-MD-02. Forest Laboratories," 2001, $121,000. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of Memantine in patients with moderate to severe dementia of the Alzheimer’s type: MEM-MD-01." Forest Laboratories, 2001, $121,000. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"A multi-center, pivotal, safety and efficacy study of the Neuro-Cybernetic Prosthesis (NCP) System in patients with depression," Cyberonics, 2000-2001, $159,270. Sub-investigator with others. Principal investigator: Conway, C.
"A multi-center, open-label, humanitarian study with sublingual Org 5222," Organon, 2001. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"Long-term maintenance of subjects with Schizophrenia with Org 5222 Protocol 041-505," Organon 2001. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"A double-blind, three-armed, fixed dose, placebo-controlled, dose-finding study with sublingual Org 5222 in subjects with acute phase schizophrenia," Organon, 2001, $304,818. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"Comparative effectiveness of anti-psychotic medications in patients with schizophrenia (CATIE Project)," National Institute of Mental Health, 2000-2004, $342,611. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"Comparative effectiveness of anti-psychotic medications in patients with Alzheimer’s Disease (CATIE Project)," National Institute of Mental Health, 2000-2004, $147,970. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"A randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of divalproex sodium therapy for agitation in nursing home residents with probable or possible Alzheimer’s Disease," National Institute of Mental Health, 2000-2001, $42,000. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"An open-label, long-term, flexible dose study of safety, tolerability, and therapeutic response to PNU (sonepiprazole mesylate) in patients with psychotic disorders," Pharmacia Upjohn, 2000, $103,189. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"A double-blind six month continuation protocol for patients who successfully completed protocol R-0548 followed by an optional extension phase of up to a year," Pfizer, 2000, $24,276. Sub-investigator with others. Principal investigator: Grossberg, G.T.
"A double-blind, multi-center, controlled study comparing the safety and efficacy of ziprasidone to olanzapine in patients with schizophrenia or schizoaffective disorder needing inpatient care," Pfizer, 2000, $70,632. Sub-investigator with others. Principal investigator: Grossberg, G.T.
Selected Publications
Books and Book Chapters
"Ethical considerations in the assessment and treatment of chronic pain in older adults," in M.E. Schatman, & B.L. Gant (eds.), Ethical Issues in Chronic Pain Management, (In press).
"Medico-Legal issues in pain treatment: an emphasis on Workers’ Compensation cases," in M. Grabois (ed.), A Compendium of Critical Issues in Pain Management, (Stamford, CT: PharmaCom Group, Inc., 2005), pages 26-29.
"The neuropsychology of written language interventions," in R.C. D’Amato E. Fletcher-Janzen, and C.R. Reynolds (eds.), Handbook of School Neuropsychology, (Hoboken, N.J.: John Wiley & Sons, Inc., 2005), co-author M.M. Chittooran, pages 777-803.
"Compensation claims for chronic pain: effects on evaluation and treatment," in R.H. Dworkin and W.S. Breitbart (eds.), Psychosocial Aspects of Pain: A Handbook for Health Care Providers, (Seattle, WA: IASP Press, 2004), pages 547-570.
"Assessment of pain beliefs and pain coping," in D.C. Turk and R. Melzack (eds.), Handbook of Pain Assessment, 2nd Edition, (New York: The Guilford Press, 2001), co-author D.E. DeGood, pages 320-345.
Peer-Reviewed Articles
"Clinical and Social Predictors of Application for Social Security Disability Insurance by Workers' Compensation Claimants with Low Back Pain," with Chibnall, J.T., Andresen, E.M., & Hadler, N.M., Journal of Occupational and Environmental Medicine, (In press).
"Effect of acetaminophen on behavior, well-being, and psychotropic medication use in nursing home residents with moderate-to-severe dementia," with Chibnall, J.T., Harman, B., & Luebbert, R.A., Journal of the American Geriatric Society, 53, (2005): 1921-1929.
"Racial and ethnic disparities in the evaluation and treatment of pain: psychological perspectives," with Chibnall, J.T, Professional Psychology: Research and Practice, 36, (2005): 595-601.
"Race and socioeconomic differences in post-settlement outcomes for African American and Caucasian Workers’ Compensation claimants with low back injuries," with Chibnall, Andresen, E.M., & Hadler, N.M. J.T., Pain, 114, (2005): 462-472.
"Factor structure of the Pain Disability Index (PDI) in Workers’ Compensation claimants with low back injuries," with Chibnall, J.T., Archives of Physical Medicine and Rehabilitation, 86, (2005): 1141-1146.
"Effect of treatment success and empathy on surgeon attributions for back surgery outcomes," with Chibnall, J.T., Luebbert, A., & Sutter, C., Journal of Behavioral Medicine, 28, (2005): 301-12.
"Confirmatory factor analysis of the Pain Catastrophizing Scale in African American and Caucasian Workers’ Compensation claimants with low back injuries," with Chibnall, J.T., Pain, 113, (2005): 369-375.
"Disparities in occupational back injuries: predicting pain disability from satisfaction with case management in African Americans and Caucasians," with Chibnall, J.T., Pain Medicine, 6, (2005): 39-48.
"The unequal burden of pain: disparities and differences," with Green, C.R. & Gallagher, R.M., Pain Medicine, 6, (2005): 1-2.
"Management of occupational back injuries: differences among African Americans and Caucasians," with Chibnall, J.T., Andresen, E.M., & Hadler, N.M., Pain, 112, (2004): 389-396.
"Pain rating by patients and physicians: evidence of systematic pain miscalibration," with Chibnall, J.T., Pain, 107, (2004): 192-193.
"The unequal burden of pain: confronting racial and ethnic disparities in pain," with Green, C.R., Anderson, K.O, Baker, T.A., Campbell, L.C., Decker, S., Fillingim, R.B., Kalauokalani, D.A., Lasch, K.E., Myers, C., Todd, K.H., & Vallerand, A.H., Pain Medicine, 4, (2003): 277-294.
"Pain in older sub-acute care patients: associations with clinical status and treatment," with Chibnall, J.T., Pain Medicine, 3, (2002): 231-239.
"Pain assessment in cognitively impaired and unimpaired older adults: a comparison of four scales," with Chibnall, J.T., Pain, 92, (2001): 173-186.
"Work injury management of refractory low back pain: relations with ethnicity, legal representation, and diagnosis," with Chibnall, J.T., Pain, 91, (2001): 47-56.
"Internist judgments of chronic low back pain," with Chibnall, J.T., & Dabney, A., Pain Medicine, 1, (2000): 231-237.
"Assessing pain in older adults," International Psychogeriatrics, 12, (2000): 421-424.
"Disability management of low back injuries by employer-retained physicians: ratings and costs," with Chibnall, J.T. & Merys, S., American Journal of Industrial Medicine, 38, (2000): 529-538.
"Pain and behavioral disturbances in the cognitively impaired older adult: assessment and treatment issues," with Grossberg, G.T., Fine, P.G., & Sherman, L.K., Annals of Long-Term Care, 8 (Suppl), (2000): 1-7.
Book Reviews
"Mind matters: psychological interventions for chronic pain," Clinical Journal of Pain, (in press).
"The rehabilitation of back pain," Journal of Pain and Symptom Management, 13, (1997): 365-367.
Invited Presentations and Published Abstracts
“Catholic Healthcare in the Genomic Future,” Florida Catholic Conference 2005 Meeting of Healthcare Executives & Bishops, Orlando Florida.
"The Cancer Pain Inventory: A measure of the impact of malignant pain," with Deshields, T.L., Jeffe, D., Naughton, M., & Trinkaus, K., 3rd Annual Meeting of the American Psychosocial Oncology Society, Amelia Island, Florida, February 2006.
"Medico-legal issues in pain treatment with an emphasis on Workers’ Compensation," 21st Annual Meeting of the American Academy of Pain Medicine, Palm Springs, California, February 2005.
"Racial and socioeconomic disparities in occupational back injuries," 21st Annual Meeting of the American Academy of Pain Medicine, Palm Springs, California, February 2005.
"IRB Member Judgments of Vulnerability and Risk: Medical versus Psychiatric Studies," with Luebbert, R.L., Chibnall, J.T., & Deshields, T.L., 19th Annual Meeting of the Applied Research Ethics National Association, San Diego, California, October 2004.
"Disparities in pain treatment across medical settings," with Carr, D., Green, C., & Todd, K., 2nd Joint Scientific Meeting of the American Pain Society and Canadian Pain Society, May 2004.
"Assessing arthritis pain in older adults with dementia," 10th Annual Meeting of the Midwest Pain Society, September 2003.
"Cancer patients’ perceptions and concerns about pain differ by severity of pain," with Deshields, T., Jeffe, D., Hawkins, J., & Naughton, M., 6th World Congress of Psycho-Oncology, April 2003.
"Fears about cancer pain: what patients and health professionals tell us," with Deshields, T., Jeffe, D., Hawkins, J., & Naughton, M., 6th World Congress of Psycho-Oncology, April 2003.
"Effect of expectancies on social judgments of disability claimants with low back pain," with Chibnall, J.T., 22nd Annual Meeting of the American Pain Society, March 2003.
"Surgeon attributions of causality following successful and failed treatments," with Chibnall, J.T., Sutter, C., & Peacock, J., 22nd Annual Meeting of the American Pain Society, March 2003.
"A comparison of four measures of pain intensity in impaired and unimpaired older adults," with Chibnall, J.T., 19th Annual Meeting of the American Pain Society, November 2000.
"Geriatric pain: assessment and treatment in subacute care," with Chibnall, J.T., 19th Annual Meeting of the American Pain Society, November, 2000.
"Pain and behavioral disturbances in the cognitively impaired older adult: assessment and treatment issues," with Grossberg, G.T., Sherman, L.K., & Fine, P.G., Annual Meeting of the American Geriatrics Society, May 2000.
"The hidden dimension of dementia care: pain and its impact," with Grossberg, G.T., Sherman, L.K., & Fine, P.G., 23rd Annual Meeting of the American Medical Directors Association, March 2000.
Honors and Awards
Chair, Biomedical Institutional Review Board, Saint Louis University, 1/04 – present.
Organizations and Committees
Professional Affiliations
American Psychological Association, Member since 1982
Society of Behavioral Medicine, Member since 1982
American Pain Society, Member since 1982
International Association for the Study of Pain, Member since 1984
American Academy of Pain Medicine, Scientific member since 2004
University Service
Saint Louis University Institutional Review Board, Member, 2000-present
Health Science Center Research Planning Committee, Member, 2000-present
Operations Committee for SoLUtions project, Member, 2001-present
University Task Force on Conflict of Interest, Member, 2001
Department of Psychiatry Executive Committee, Member, 2000-present
Department of Psychiatry Medical Student Education Committee, Member, 1999- present.
General Advisory Committee for the General Clinical Research Center, Member, 2002-
Internal Review Committee for the Department of Neurology, Member, 2002.
St. Louis University Institutional Review Board, Chair, 1/04 – present.
Albert Gnaegi Center for Health Care Ethics
Mailing Address: Albert Gnaegi Center for Health Care Ethics
221 North Grand Blvd., St. Louis, MO 63103-2006
Campus address: O'Brien Hall, Frost Campus
Telephone: (314) 977-6661
Fax: (314) 977-5150
|
